Ad is loading...
JSCAX
Price
$18.95
Change
-$0.14 (-0.73%)
Updated
Nov 15 closing price
VISVX
Price
$49.63
Change
-$0.34 (-0.68%)
Updated
Nov 15 closing price
Ad is loading...

JSCAX vs VISVX

Header iconJSCAX vs VISVX Comparison
Open Charts JSCAX vs VISVXBanner chart's image
JHancock Small Cap Value A
Price$18.95
Change-$0.14 (-0.73%)
VolumeN/A
CapitalizationN/A
Vanguard Small Cap Value Index I
Price$49.63
Change-$0.34 (-0.68%)
VolumeN/A
CapitalizationN/A
JSCAX vs VISVX Comparison Chart
Loading...
View a ticker or compare two or three
VS
JSCAX vs. VISVX commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JSCAX is a Buy and VISVX is a Buy.

FUNDAMENTALS
Fundamentals
VISVX has more cash in the bank: 57.6B vs. JSCAX (569M). VISVX pays higher dividends than JSCAX: VISVX (1.90) vs JSCAX (0.39). JSCAX was incepted earlier than VISVX: JSCAX (11 years) vs VISVX (27 years). JSCAX is a more actively managed with annual turnover of: 49.00 vs. VISVX (16.00). JSCAX has a lower initial minimum investment than VISVX: JSCAX (1000) vs VISVX (3000). VISVX annual gain was more profitable for investors over the last year : 28.71 vs. JSCAX (12.19). VISVX return over 5 years is better than : 57.32 vs. JSCAX (-10.78).
JSCAXVISVXJSCAX / VISVX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence11 years27 years-
Gain YTD10.11015.43366%
Front LoadN/AN/A-
Min. Initial Investment1000300033%
Min. Initial Investment IRAN/AN/A-
Net Assets569M57.6B1%
Annual Yield % from dividends0.391.9020%
Returns for 1 year12.1928.7142%
Returns for 3 years-26.5013.23-200%
Returns for 5 years-10.7857.32-19%
Returns for 10 years-2.44108.21-2%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
DX12.420.04
+0.32%
Dynex Capital
PNR105.920.06
+0.06%
Pentair plc
TGNA17.64-0.47
-2.60%
TEGNA
HCTI1.16-0.04
-3.33%
Healthcare Triangle
ATOS1.28-0.09
-6.57%
Atossa Therapeutics